Literature DB >> 10831523

Clinical profile and outcome of idiopathic restrictive cardiomyopathy.

N M Ammash1, J B Seward, K R Bailey, W D Edwards, A J Tajik.   

Abstract

BACKGROUND: Idiopathic restrictive cardiomyopathy is a poorly recognized entity of unknown cause characterized by nondilated, nonhypertrophied ventricles with diastolic dysfunction resulting in dilated atria and variable systolic function. METHODS AND
RESULTS: Between 1979 and 1996, 94 patients (61% women) 10 to 90 years old (mean, 64 years) met strict morphological echocardiographic criteria for idiopathic restrictive cardiomyopathy, mainly dilated atria with nonhypertrophied, nondilated ventricles. None had known infiltrative disease, hypertension of >5 years' duration, or cardiac or systemic conditions associated with restrictive filling. Nineteen percent were in NYHA class I, 53% in class II, and 28% in class III or IV. Atrial fibrillation was noted in 74% of patients and systolic dysfunction in 16%. Follow-up (mean, 68 months) was complete for 93 patients (99%). At follow-up, 47 patients (50%) had died, 32 (68%) of cardiovascular causes. Four had heart transplantation. The death rate compared with actuarial statistics was significantly higher than expected (P<0.0001). Kaplan-Meier 5-year survival was 64%, compared with expected survival of 85%. Multivariate analysis using proportional hazards showed that the risk of death approximately doubles with male sex (hazard ratio [HR] = 2.1), left atrial dimension >60 mm (HR = 2.3), age >70 years (HR = 2.0), and each increment of NYHA class (HR = 2.0).
CONCLUSIONS: Idiopathic restrictive cardiomyopathy or nondilated, nonhypertrophic ventricles with marked biatrial dilatation, as defined morphologically by echocardiography, affects predominantly elderly patients but can occur in any age group. Patients present with systemic and pulmonary venous congestion and atrial fibrillation and have a poor prognosis, particularly men >70 years old with higher NYHA class and left atrial dimension >60 mm.

Entities:  

Mesh:

Year:  2000        PMID: 10831523     DOI: 10.1161/01.cir.101.21.2490

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  57 in total

Review 1.  Constrictive pericarditis in the modern era: a diagnostic dilemma.

Authors:  R A Nishimura
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 2.  Differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis.

Authors:  E W Hancock
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

3.  Restrictive Cardiomyopathy.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

Review 4.  Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

Review 5.  Genetics of inherited cardiomyopathy.

Authors:  Daniel Jacoby; William J McKenna
Journal:  Eur Heart J       Date:  2011-08-02       Impact factor: 29.983

6.  Massive intra-atrial thrombosis in an 11-year-old child with restrictive cardiomyopathy.

Authors:  Iyad A Al-Ammouri
Journal:  Pediatr Cardiol       Date:  2010-02-11       Impact factor: 1.655

7.  Idiopathic restrictive cardiomyopathy in children.

Authors:  L M Russo; S A Webber
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

8.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

9.  Association of the metabolic syndrome with pulmonary venous hypertension.

Authors:  Ivan M Robbins; John H Newman; Roger F Johnson; Anna R Hemnes; Richard D Fremont; Robert N Piana; David X Zhao; Daniel W Byrne
Journal:  Chest       Date:  2009-02-02       Impact factor: 9.410

Review 10.  Cardiac troponin mutations and restrictive cardiomyopathy.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto; David Dweck; James D Potter
Journal:  J Biomed Biotechnol       Date:  2010-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.